The 20th International Congress of Therapeutic Drug Monitoring & Clinical Toxicology (IATDMCT 2022) will be held from Sunday 18th to Wednesday 21st September 2022 in Prague, Czech Republic. IATDMCT 2022 will be the 20th opportunity for experts in Therapeutic Drug Monitoring and Clinical Toxicology from the whole world to meet and shape the future of our field.

The theme of the congress is Bridging the Troubled Waters.

Registration is Open!

IMPORTANT DATES

• 17 September 2022: Regular registration deadline
• 18 September 2022: Pre-congress symposium
• 18–21 September 2022: Congress days

Click here for the Congress programme

Professor Milan Grundmann, the organizer and the president of the conference address the following message to all of us:

Dear IATDMCT members,

Ladies and Gentlemen,

Time has not only moved forward, but has also progressed significantly, and the date of our world conference has come significantly closer. As you may have already noticed, the Prague conference was changed to a hybrid conference, especially given the international economic situation and potentially COVID infections. That is why we complied with many voices demanding the creation of a hybrid conference. This interest has not been supported by an increased number of online registered participants, even though the on line registration fees listed on the IATDMCT website are minimal. After registering, you will not only have online access for the duration of the conference, but also for the next three months after its end, to be able to study all the materials presented.

The change from in person to the hybrid form of the conference also has an effect on the increasing costs required for the successful course of the conference. Out of the total number of 800 IATDMCT members, less than 300 participants have signed up so far.

We would like to ask you to participate online in our conference, the program of which you can read on the IATDMCT website. This program is really very interesting, both from a medical and scientific point of view.

There is also the possibility to sign up for active participation by sending a late-late abstract. I believe that you are interested in this possibility and that you will support the successful course of your TDM and CT conference.

I am very much looking forward to seeing you in Prague, either in person or online.

Prof. Milan Grundmann
Organizer and President of IATDMCT- Annual Conference 2022

The Host Organizing Committee has decided to hold this year's IATDMCT Congress in a hybrid format.

At the Congress you will:

• expand your knowledge
• explain your ideas
• hear industry insight
• network with your global TDM & CT colleagues

The Congress will have:

• 36 Concurrent sessions
• 150+ Scientific talks
• 250+ Speakers
• 105 Posters
• 61 Symposia
• 4 Workshops
• 2 Debates
• 2 Roundtable sessions

The scientific programme of IATDMCT 2022 is continuously updated on the website!

At the 2022 IATDMCT Congress in Prague, the venue for the 2026 Congress will be chosen and announced to members at the Annual General Assembly on Wednesday afternoon (September 21).

Join us in maintaining the IATDMCT membership! We look forward to inspiring many further colleagues who share with us the idea of an optimized and personalized drug treatment to join us in IATDMCT. Please ensure you renew your membership in order to retain your IATDMCT member benefits.

Our 2022 Member-Get-A Member Campaign now is up and running! Members are invited to inform their colleagues (who are not members yet) about the benefits of membership. Let’s build a strong partnership together!

Campaign Deadline: August 31, 2022.

As usual the top recruiter (with at least 50%-paying members) will gain a free registration for the IATDMCT Congress 2022 in Prague.

Click here for complete participation details!

Find the latest news and follow our IATDMCT institutional page on LinkedIn!

Click here to access the page!

Stay ahead with the latest scientific research developments in the fields of TDM and CT!

The monthly Therapeutic Drug Monitoring column provides you with the latest posts of ahead-of-print. Bringing to you articles posted online July 13 – August 19, 2022:

ORIGINAL ARTICLES:

• Evaluation of a Capillary Microsampling Device for Analyzing Plasma Lenvatinib Concentration in Patients with Hepatocellular Carcinoma
  Saito, Akihiro; Kikuchi, Masafumi; Matsumoto, Yuko; Sugawara, Erina; Takao, Gesshu; Inomata, Hayato; Takahashi, Akane; Sato, Yuji; Kumondai, Masaki; Sato, Yu; Sato, Toshihiro; Ninomiya, Masashi; Inoue, Jun; Maekawa, Masamitsu; Mano, Nariyasu
• Relationship between Plasmatic Metformin Concentration and Renal Replacement Therapy: A Multicenter Cohort Study
  Demaretz, Lise; Claisse, Guillaume; Fanton-D’Andon, Cornélie; Crepet, Françoise; Herda, Adel; Marin, Clémence; Gonzalo, Philippe; Mariat, Christophe; Delavenne, Xavier; Launay, Manon
• Results from a proficiency testing pilot for immunosuppressant microsampling assays
  Veenhof, Herman; Koster, Remco A.; Junier, Lenneke A.T.; Zweipfenning, Peter; Touw, Daan J.
• An Ultra-High Performance Liquid Chromatography-Tandem Mass Spectrometry Method for Simultaneous Determination of Four β-Lactam Antibiotics, Tazobactam, and Linezolid in Human Plasma Samples
  Piestansky, Juraj; Cizmarova, Ivana; Prof, Peter Mikus; Parrak, Vojtech; Babiak, Pavel; Secnik jr, Peter; Secnik, Peter; Kovac, Andrej
• Reproducible Quantification of Unbound Fractions of Four Beta-lactam Antibiotics: Ultrafiltration versus Microdialysis of Spiked Healthy Donor Plasma
  Beijer, Gustaf; Clarin, Leona; Östervall, Jennie; Barclay, Victoria; Eliasson, Erik

REVIEW ARTICLES:

• Therapeutic drug monitoring and dosage adjustments of immunosuppressive drugs when combined with nirmatrelvir/ritonavir in patients with COVID-19
  Lemaitre, Florian; Budde, Klemens; Van Gelder, Teun; Bergan, Stein; Lawson, Roland; Noceti, Ofelia; Venkataramanan, Raman; Elens, Laure; Moes, Dirk Jan A.R.; Hesselink, Dennis A.; Pawinski, Tomasz; Johnson-Davis, Kamisha L.; De Winter, Brenda C.M.; Pattanaik, Smita; Brunet, Mercè; Masuda, Satohiro; Langman, Loralie J.
• Optimum Methotrexate Exposure in Patients with Suspected or Confirmed CNS Invasive Hematological Malignancies: A Systematic Critical Review
  Faria, Monteiro, Joaquim; Rita, Damas; Rui, Bergantim; Fernanda, Trigo

SHORT COMMUNICATION:

• Passage of venlafaxine in human milk during 12 months of lactation: a case report Letter to the editor
  ChemD, Sara Baldelli; Pogliani, Laura; Schneider, Laura; Clementi, Emilio; Zuccotti, Gianvincenzo; Cattaneo, Dario

LETTER TO THE EDITOR:

• The challenges of performing a trial to evaluate the effect of therapeutic drug monitoring-based antimicrobial therapy – Letter to the Editor
  He, Na; Yang, Li; Zhai, Suodi

››Submit your high quality research – Information for authors.

The Communication Committee would like to inform the membership that advertisements for professional positions (Ph.D. and Post-Doc job opportunities) in the field of TDM/CT, will be published in the E-news instead of on the IATDMCT website. Please e-mail the office with the advertisement for the position and it will be published in an upcoming monthly E-news. (IATDMCT office email: info@iatdmct.org)

Below please find informative links about the current situation, which specifically addresses the rapid identification of COVID-19 cases as well as adverse reactions due to interaction of drugs:

• The IATDMCT website provides a list of COVID-19 resources
• Drugs used to treat COVID-19 that may interact with other medication
• ASHP's Covid-19 Resource Center

» Click here to Post an Event on our Online Events Calendar today!

Visit the IATDMCT Events Calendar and stay informed about the upcoming TDM and CT Meetings. By doing this you can comfortably and directly reach all related online resources.

JOIN US FOR A FREE IATDMCT WEBINAR!

Validation of Bioanalytical Methods
September 7, 2022
4:30 p.m. – 6:00 p.m. (India Standard Time)

Moderators:
Prof. Nusrat Shafiq
Prof. Smita Pattanaik
Dr. Ashish Kakkar

Speakers:
Validation parameters for Bioanalytical method – Dr. Nanda Gamad, M.D, D.M
Walking through an example of method validation – Dr. Ritika Kondel, MSc, PhD
External Proficiency Testing in TDM Laboratory – Dr. Soumya Vij, MD, and Dr. Naveen Murali, M.D

Host Institution:
Clinical Pharmacology Unit
Department of Pharmacology
Post Graduate Institute of Medical Education and Research
Chandigarh, India

All IATDMCT members are welcome to join this webinar, and the registration is free!

To register: click here to receive your Zoom login.

Join your peers at the 2022 ACCP Global Conference on Clinical Pharmacy! Early Registration Deadline is September 19.

Click here for more information!

The Iberoamerican Pharmacometric Network (RedIF) 2022 congress will take place in Porto Alegre, Brazil from October 5th to 7th. Late abstracts can be sent until August 28.

Please visit the website for more information: https://redifcongress2022.eventize.com.br/index.php?language=en.

Co-editor: Manuela Neuman
Co-editor: Ryuji Kato
Co-editor: Miao Yan

NOTE: Items appearing in the IATDMCT monthly E-News do not necessarily have the endorsement of the Association.